Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous polymyxin B pharmacokinetics in pediatric patients
TCTR20261028008Enrolling by invitation
- Sponsor
- Jiranan Janda
- Start
- Sep 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of polymyxin B in Gram-negative bacterial infection (2 arms), sponsored by Jiranan Janda. Primary endpoint: Pharmacokinetic parameters of polymyxin B at steady state. Started Sep 2026; status: enrolling by invitation.
02
Drugs
polymyxin B
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on TCTR20261028008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261028008.